Alto Neuroscience, Inc. (ANRO)
24.98
+0.95
(+3.95%)
USD |
NYSE |
Oct 09, 13:39
Alto Neuroscience EPS Diluted (Quarterly) : -0.6456 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6456 |
| March 31, 2026 | -0.7976 |
| December 31, 2025 | -0.5069 |
| September 30, 2025 | -0.5232 |
| June 30, 2025 | -0.654 |
| March 31, 2025 | -0.5608 |
| December 31, 2024 | -0.5633 |
| September 30, 2024 | -0.6223 |
| Date | Value |
|---|---|
| June 30, 2024 | -0.5948 |
| March 31, 2024 | -0.4991 |
| December 31, 2023 | -0.4172 |
| September 30, 2023 | -0.3574 |
| June 30, 2023 | -0.3222 |
| March 31, 2023 | -0.0003 |
| December 31, 2022 | -0.2992 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.64M |
| Total Expenses (Quarterly) | 27.64M |
| Enterprise Value | 622.87M |
| Earnings Yield | -9.90% |
| Normalized Earnings Yield | -9.862 |